Report cover image

Global Amlodipine Besylate Tablets Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 195 Pages
SKU # APRC20362330

Description

Summary

According to APO Research, The global Amlodipine Besylate Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Amlodipine Besylate Tablets include AstraZeneca, Bristol-Myers Squibb, North China Pharmaceutical, China Resources Double-Crane Pharmaceutical, Pfizer, Jingfeng Pharmaceutical, Roche, Sanofi and Shanghai Shyndec Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Amlodipine Besylate Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Amlodipine Besylate Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Amlodipine Besylate Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amlodipine Besylate Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Amlodipine Besylate Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Amlodipine Besylate Tablets sales, projected growth trends, production technology, application and end-user industry.

Amlodipine Besylate Tablets Segment by Company

AstraZeneca
Bristol-Myers Squibb
North China Pharmaceutical
China Resources Double-Crane Pharmaceutical
Pfizer
Jingfeng Pharmaceutical
Roche
Sanofi
Shanghai Shyndec Pharmaceutical
Yangtze River Pharmaceutical
Amlodipine Besylate Tablets Segment by Type

5 Milligrams
10 Milligrams
Amlodipine Besylate Tablets Segment by Application

Hospital
Pharmacy
Amlodipine Besylate Tablets Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amlodipine Besylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amlodipine Besylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amlodipine Besylate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Amlodipine Besylate Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Amlodipine Besylate Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amlodipine Besylate Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Amlodipine Besylate Tablets Market by Type
1.2.1 Global Amlodipine Besylate Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 5 Milligrams
1.2.3 10 Milligrams
1.3 Amlodipine Besylate Tablets Market by Application
1.3.1 Global Amlodipine Besylate Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Amlodipine Besylate Tablets Market Dynamics
2.1 Amlodipine Besylate Tablets Industry Trends
2.2 Amlodipine Besylate Tablets Industry Drivers
2.3 Amlodipine Besylate Tablets Industry Opportunities and Challenges
2.4 Amlodipine Besylate Tablets Industry Restraints
3 Global Market Growth Prospects
3.1 Global Amlodipine Besylate Tablets Revenue Estimates and Forecasts (2020-2031)
3.2 Global Amlodipine Besylate Tablets Revenue by Region
3.2.1 Global Amlodipine Besylate Tablets Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Amlodipine Besylate Tablets Revenue by Region (2020-2025)
3.2.3 Global Amlodipine Besylate Tablets Revenue by Region (2026-2031)
3.2.4 Global Amlodipine Besylate Tablets Revenue Market Share by Region (2020-2031)
3.3 Global Amlodipine Besylate Tablets Sales Estimates and Forecasts 2020-2031
3.4 Global Amlodipine Besylate Tablets Sales by Region
3.4.1 Global Amlodipine Besylate Tablets Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Amlodipine Besylate Tablets Sales by Region (2020-2025)
3.4.3 Global Amlodipine Besylate Tablets Sales by Region (2026-2031)
3.4.4 Global Amlodipine Besylate Tablets Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Amlodipine Besylate Tablets Revenue by Manufacturers
4.1.1 Global Amlodipine Besylate Tablets Revenue by Manufacturers (2020-2025)
4.1.2 Global Amlodipine Besylate Tablets Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Amlodipine Besylate Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Amlodipine Besylate Tablets Sales by Manufacturers
4.2.1 Global Amlodipine Besylate Tablets Sales by Manufacturers (2020-2025)
4.2.2 Global Amlodipine Besylate Tablets Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Amlodipine Besylate Tablets Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Amlodipine Besylate Tablets Sales Price by Manufacturers (2020-2025)
4.4 Global Amlodipine Besylate Tablets Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Amlodipine Besylate Tablets Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Amlodipine Besylate Tablets Manufacturers, Product Type & Application
4.7 Global Amlodipine Besylate Tablets Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Amlodipine Besylate Tablets Market CR5 and HHI
4.8.2 2024 Amlodipine Besylate Tablets Tier 1, Tier 2, and Tier 3
5 Amlodipine Besylate Tablets Market by Type
5.1 Global Amlodipine Besylate Tablets Revenue by Type
5.1.1 Global Amlodipine Besylate Tablets Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Amlodipine Besylate Tablets Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Amlodipine Besylate Tablets Revenue Market Share by Type (2020-2031)
5.2 Global Amlodipine Besylate Tablets Sales by Type
5.2.1 Global Amlodipine Besylate Tablets Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Amlodipine Besylate Tablets Sales by Type (2020-2031) & (K Units)
5.2.3 Global Amlodipine Besylate Tablets Sales Market Share by Type (2020-2031)
5.3 Global Amlodipine Besylate Tablets Price by Type
6 Amlodipine Besylate Tablets Market by Application
6.1 Global Amlodipine Besylate Tablets Revenue by Application
6.1.1 Global Amlodipine Besylate Tablets Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Amlodipine Besylate Tablets Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Amlodipine Besylate Tablets Revenue Market Share by Application (2020-2031)
6.2 Global Amlodipine Besylate Tablets Sales by Application
6.2.1 Global Amlodipine Besylate Tablets Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Amlodipine Besylate Tablets Sales by Application (2020-2031) & (K Units)
6.2.3 Global Amlodipine Besylate Tablets Sales Market Share by Application (2020-2031)
6.3 Global Amlodipine Besylate Tablets Price by Application
7 Company Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Comapny Information
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 AstraZeneca Amlodipine Besylate Tablets Product Portfolio
7.1.5 AstraZeneca Recent Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Comapny Information
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolio
7.2.5 Bristol-Myers Squibb Recent Developments
7.3 North China Pharmaceutical
7.3.1 North China Pharmaceutical Comapny Information
7.3.2 North China Pharmaceutical Business Overview
7.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
7.3.5 North China Pharmaceutical Recent Developments
7.4 China Resources Double-Crane Pharmaceutical
7.4.1 China Resources Double-Crane Pharmaceutical Comapny Information
7.4.2 China Resources Double-Crane Pharmaceutical Business Overview
7.4.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
7.4.5 China Resources Double-Crane Pharmaceutical Recent Developments
7.5 Pfizer
7.5.1 Pfizer Comapny Information
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Pfizer Amlodipine Besylate Tablets Product Portfolio
7.5.5 Pfizer Recent Developments
7.6 Jingfeng Pharmaceutical
7.6.1 Jingfeng Pharmaceutical Comapny Information
7.6.2 Jingfeng Pharmaceutical Business Overview
7.6.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
7.6.5 Jingfeng Pharmaceutical Recent Developments
7.7 Roche
7.7.1 Roche Comapny Information
7.7.2 Roche Business Overview
7.7.3 Roche Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Roche Amlodipine Besylate Tablets Product Portfolio
7.7.5 Roche Recent Developments
7.8 Sanofi
7.8.1 Sanofi Comapny Information
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sanofi Amlodipine Besylate Tablets Product Portfolio
7.8.5 Sanofi Recent Developments
7.9 Shanghai Shyndec Pharmaceutical
7.9.1 Shanghai Shyndec Pharmaceutical Comapny Information
7.9.2 Shanghai Shyndec Pharmaceutical Business Overview
7.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
7.9.5 Shanghai Shyndec Pharmaceutical Recent Developments
7.10 Yangtze River Pharmaceutical
7.10.1 Yangtze River Pharmaceutical Comapny Information
7.10.2 Yangtze River Pharmaceutical Business Overview
7.10.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
7.10.5 Yangtze River Pharmaceutical Recent Developments
8 North America
8.1 North America Amlodipine Besylate Tablets Market Size by Type
8.1.1 North America Amlodipine Besylate Tablets Revenue by Type (2020-2031)
8.1.2 North America Amlodipine Besylate Tablets Sales by Type (2020-2031)
8.1.3 North America Amlodipine Besylate Tablets Price by Type (2020-2031)
8.2 North America Amlodipine Besylate Tablets Market Size by Application
8.2.1 North America Amlodipine Besylate Tablets Revenue by Application (2020-2031)
8.2.2 North America Amlodipine Besylate Tablets Sales by Application (2020-2031)
8.2.3 North America Amlodipine Besylate Tablets Price by Application (2020-2031)
8.3 North America Amlodipine Besylate Tablets Market Size by Country
8.3.1 North America Amlodipine Besylate Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Amlodipine Besylate Tablets Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Amlodipine Besylate Tablets Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Amlodipine Besylate Tablets Market Size by Type
9.1.1 Europe Amlodipine Besylate Tablets Revenue by Type (2020-2031)
9.1.2 Europe Amlodipine Besylate Tablets Sales by Type (2020-2031)
9.1.3 Europe Amlodipine Besylate Tablets Price by Type (2020-2031)
9.2 Europe Amlodipine Besylate Tablets Market Size by Application
9.2.1 Europe Amlodipine Besylate Tablets Revenue by Application (2020-2031)
9.2.2 Europe Amlodipine Besylate Tablets Sales by Application (2020-2031)
9.2.3 Europe Amlodipine Besylate Tablets Price by Application (2020-2031)
9.3 Europe Amlodipine Besylate Tablets Market Size by Country
9.3.1 Europe Amlodipine Besylate Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Amlodipine Besylate Tablets Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Amlodipine Besylate Tablets Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Amlodipine Besylate Tablets Market Size by Type
10.1.1 China Amlodipine Besylate Tablets Revenue by Type (2020-2031)
10.1.2 China Amlodipine Besylate Tablets Sales by Type (2020-2031)
10.1.3 China Amlodipine Besylate Tablets Price by Type (2020-2031)
10.2 China Amlodipine Besylate Tablets Market Size by Application
10.2.1 China Amlodipine Besylate Tablets Revenue by Application (2020-2031)
10.2.2 China Amlodipine Besylate Tablets Sales by Application (2020-2031)
10.2.3 China Amlodipine Besylate Tablets Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Amlodipine Besylate Tablets Market Size by Type
11.1.1 Asia Amlodipine Besylate Tablets Revenue by Type (2020-2031)
11.1.2 Asia Amlodipine Besylate Tablets Sales by Type (2020-2031)
11.1.3 Asia Amlodipine Besylate Tablets Price by Type (2020-2031)
11.2 Asia Amlodipine Besylate Tablets Market Size by Application
11.2.1 Asia Amlodipine Besylate Tablets Revenue by Application (2020-2031)
11.2.2 Asia Amlodipine Besylate Tablets Sales by Application (2020-2031)
11.2.3 Asia Amlodipine Besylate Tablets Price by Application (2020-2031)
11.3 Asia Amlodipine Besylate Tablets Market Size by Country
11.3.1 Asia Amlodipine Besylate Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Amlodipine Besylate Tablets Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Amlodipine Besylate Tablets Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Amlodipine Besylate Tablets Market Size by Type
12.1.1 SAMEA Amlodipine Besylate Tablets Revenue by Type (2020-2031)
12.1.2 SAMEA Amlodipine Besylate Tablets Sales by Type (2020-2031)
12.1.3 SAMEA Amlodipine Besylate Tablets Price by Type (2020-2031)
12.2 SAMEA Amlodipine Besylate Tablets Market Size by Application
12.2.1 SAMEA Amlodipine Besylate Tablets Revenue by Application (2020-2031)
12.2.2 SAMEA Amlodipine Besylate Tablets Sales by Application (2020-2031)
12.2.3 SAMEA Amlodipine Besylate Tablets Price by Application (2020-2031)
12.3 SAMEA Amlodipine Besylate Tablets Market Size by Country
12.3.1 SAMEA Amlodipine Besylate Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Amlodipine Besylate Tablets Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Amlodipine Besylate Tablets Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Amlodipine Besylate Tablets Value Chain Analysis
13.1.1 Amlodipine Besylate Tablets Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Amlodipine Besylate Tablets Production Mode & Process
13.2 Amlodipine Besylate Tablets Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Amlodipine Besylate Tablets Distributors
13.2.3 Amlodipine Besylate Tablets Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.